ZL Wang, AM Bramley, A McNamara, PD Pare and TR Bai
University of British Columbia Pulmonary Research Laboratory, St. Paul's Hospital, Vancouver, Canada.

We tested the hypothesis that the regular inhalation of a beta 2- adrenergic receptor (beta 2AR) agonist increases airway responsiveness in guinea pigs. A potent beta 2AR agonist, fenoterol hydrobromide, in sublaryngeal doses equivalent to maximal doses used in the treatment of asthma on a weight basis (5.28 micrograms/kg), was administered by nebulizer three times a day for 6 weeks to normal adolescent guinea pigs (FEN, n = 10) and to ovalbuminsensitized guinea pigs challenged twice weekly with ovalbumin (OA + FEN, n = 20), although not in the 12 h prior to or 4 h after antigen challenge. Controls included saline- treated normal animals (CON, n = 10) and ovalbumin-sensitized animals treated with repeated antigen challenge and saline (OA, n = 20). At 72 h after the last administration of saline, fenoterol, and ovalbumin, the dose-response relationship between pulmonary resistance (RL) and nebulized acetylcholine (ACh) was measured. RLmax increased 2-fold and the ACh concentration causing a 10-fold increase in RL (PC10) decreased 4-fold in the FEN, OA, and OA + FEN groups as compared to the CON group. In the FEN, OA, and OA + FEN groups, in vitro tracheal smooth- muscle contractile responses to maximal concentrations of acetylcholine increased 2-fold, and this increase was not due to increased smooth- muscle mass. There was no evidence for beta 2AR desensitization as judged by in vitro tracheal smooth-muscle relaxant responses to fenoterol. These results suggest that chronic beta 2AR stimulation increases airway smooth-muscle contractility and in vivo airways responsiveness to a degree similar to that induced by chronic antigen exposure. A similar effect in human asthmatics may explain the adverse effects observed during prolonged treatment with these drugs.

This article has been cited by other articles:

				R. Gosens, I. S. T. Bos, J. Zaagsma, and H. Meurs Protective Effects of Tiotropium Bromide in the Progression of Airway Smooth Muscle Remodeling Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1096 - 1102. [Abstract] [Full Text] [PDF]

				J. A. Whitsett, C. J. Bachurski, K. C. Barnes, P. A. Bunn Jr., L. M. Case, D. N. Cook, D. Crooks, M. W. Duncan, L. Dwyer-Nield, R. C. Elston, et al. Functional Genomics of Lung Disease Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2/S1): S1 - S81. [Full Text] [PDF]

				C. Faisy, E. Naline, J.-L. Diehl, X. Emonds-Alt, T. Chinet, and C. Advenier In vitro sensitization of human bronchus by beta 2-adrenergic agonists Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1033 - L1042. [Abstract] [Full Text] [PDF]

				N. J. Vanacker, E. Palmans, R. A. Pauwels, and J. C. Kips Effect of Combining Salmeterol and Fluticasone on the Progression of Airway Remodeling Am. J. Respir. Crit. Care Med., October 15, 2002; 166(8): 1128 - 1134. [Abstract] [Full Text] [PDF]

				A Kamachi, M Munakata, Y Nasuhara, M Nishimura, Y Ohtsuka, M Amishima, T Takahashi, Y Homma, and Y Kawakami Enhancement of goblet cell hyperplasia and airway hyperresponsiveness by salbutamol in a rat model of atopic asthma Thorax, January 1, 2001; 56(1): 19 - 24. [Abstract] [Full Text]

				X.-Y. Zhang, F.-X. Zhu, M. A. Olszewski, and N. E. Robinson Effects of enantiomers of beta 2-agonists on ACh release and smooth muscle contraction in the trachea Am J Physiol Lung Cell Mol Physiol, January 1, 1998; 274(1): L32 - L38. [Abstract] [Full Text] [PDF]

				J. Szilvassy, I. Sziklai, P. Horvath, M. Szilasi, J. Nemeth, P. Kovacs, and Z. Szilvassy Feeble bronchomotor responses in diabetic rats in association with decreased sensory neuropeptide release Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L1023 - L1030. [Abstract] [Full Text] [PDF]